// App-Quantinova.ai

70 : Bilirubin is Predictive of Transplant‐free Survival Even Within the Normal Range in Primary Biliary Cholangitis Patients

Researchers

Presenter

  • Carla F. Murillo Perez

Principal Investigators

  • Henk R. van Buuren

  • Willem J. Lammers

  • Jorn C. Goet

  • Cyriel Y. Ponsioen

  • Marco Carbone

  • Andrew Mason

  • Christophe Corpechot

  • Marlyn J. Mayo

  • Pietro Invernizzi

  • Pier Maria Battezzati

  • Annarosa Floreani

  • Albert Pares

  • Frederik Nevens

  • Kris V. Kowdley

  • Tony Bruns

  • George N. Dalekos

  • Kalliopi Zachou

  • Douglas Thorburn

  • Gideon M. Hirschfield

  • Nicholas F. LaRusso

  • Keith D. Lindor

  • Raoul Poupon

  • Palak J. Trivedi

  • Xavier Verhelst

  • Harry L. Janssen

  • Bettina E. Hansen

Medical Centers

  • Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto,

  • Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada

  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Humanitas Clinical and Research Center, Rozzano, Italy

  • University of Alberta, Edmonton, AB, Canada

  • Hospital Saint Antoine, Paris, France

  • UTSouthwestern Medical Center, Dallas, TX

  • University of Milan, Milan, Italy

  • University of Pavia, Pavia, Italy

  • Universitat de Barcelona, Barcelona, Spain

  • KU Leuven, Leuven, Belgium

  • Swedish Medical Center, Seattle, WA

  • Essen University Hospital, Essen, Germany

  • University of Larissa, Larissa, Greece

  • The Royal Marsden Hospital, London, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

  • Mayo Clinic, Rochester, MN

  • Arizona State University, Phoenix, AZ

  • Ghent University Hospital, Ghent, Belgium

Locations

  • Canada

  • Netherlands

  • Italy

  • France

  • United States

  • Spain

  • Belgium

  • Germany

  • Greece

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Primary biliary cirrhosis

Biomarkers

  • Human albumin

  • Bilirubin

Drug/Treatment

  • Alkaline phosphatase

  • Ursodeoxycholic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved